Announcements
Projects
Orgs
Project
Articles 4
Votes 0
Lilly.com

Authors 3

Investors
Eli Lilly
Company
Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial - Eli Lilly
3d
FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company - Investors | Eli Lilly and Company
~2y
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology | Eli Lilly and Company - Investors | Eli Lilly and Company
>2y
Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease | Eli Lilly and Company - Investors | Eli Lilly and Company
>2y